Berenberg Initiates Coverage On Doximity with Buy Rating, Announces Price Target of $49
Berenberg analyst Dev Weerasuriya initiates coverage on Doximity (NYSE:DOCS) with a Buy rating and announces Price Target of $49.
SVB Leerink Sees ‘Cheaper Way’ To Pharma Digital Marketing With This Stock
SVB Leerink initiated coverage on OptimizeRx Corporation (NASDAQ:OPRX) with a buy rating and a price target of $38, implying an upside of…